PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 70.76% | 18.83% | 37.62% | -17.26% | -44.83% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -99.99% | -4.59% | -9.27% | -7.45% |
| Change in Net Operating Assets | -85.59% | 290.75% | -151.76% | 77.17% | 178.22% |
| Cash from Operations | 51.45% | 57.56% | -17.24% | -12.24% | 17.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 41.99% | -- |
| Issuance of Common Stock | -- | -- | -- | 702.21% | -84.60% |
| Repurchase of Common Stock | -- | 100.00% | 16.39% | 68.66% | -27.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -100.25% | 1,388.31% | -78.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.24% | 57.77% | -186.68% | 285.60% | -109.18% |